Drug Claim Symptoms Spread Among Supplement Marketers Targeting Ebola Fears
This article was originally published in The Pink Sheet Daily
Executive Summary
The latest FDA/FTC joint warning letters advise Life Silver, Bodyhealth.com LLC and Ebola-C Inc. that their online claims render their products unapproved new drugs. FDA directs the firms to respond to an “EbolaTaskForce-CFSAN” email address rather than to an ORA address typical of most warning letters.